Thin Film Drugs Market Size by Product, Disease Indication, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2030
Overview
The Thin Film Drugs Market size was valued at USD 9.60 Billion in 2023 and the total Thin Film Drugs revenue is expected to grow at a CAGR of 11.1% from 2024 to 2030, reaching nearly USD 20.07 Billion.
Thin film drugs have emerged as an alternative to tablets or capsules due to its effective therapeutic results. The drugs are made of polymers that rapidly dissolve when kept in the mouth or buccal cavity, delivering the drug directly to systemic circulation in the body.
Increasing demand for effective drug delivery systems, coupled with increasing research to develop newer polymeric thin films are expected to increase the demand for thin film drugs. The low manufacturing cost of thin film drugs as compared to traditional dosage forms has proven to be integral market driver in the global market. However, high costs associated with the treatment is restraining the market growth.Effective therapeutic output of the drugs when compared to traditional drugs provides a lucrative opportunity for the market to grow.
To know about the Research Methodology :- Request Free Sample Report
The thin film drugs market is segmented based on product, disease indication, and region. By product, the market is divided into oral thin films, transdermal thin films, and others. Oral thin film segment is expected to exhibit highest market share at a CAGR of xx% over forecast period.
By geography, global thin film drugs market is segmented into North America, APAC, Europe, MEA& Africa and Latin America. North America is expected to exhibit highest market share at a CAGR of xx% over forecast period. As of 2018, North America thin film drug manufacturing market accounted for a share of more than 65% thanks to the structured pharmaceutical industry in the region.
Key players operating in this market are MonoSol Rx, Tesa Labtec GmbH, Pfizer, Inc., Novartis AG, and Wolters Kluwer, Solvay, Allergan plc. Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp, and Transition Therapeutics, Inc. are provided in this report. These key players are adopting various organic and inorganic growth strategies to enhance their business operations and regional presence.
The objective of the report is to present comprehensive analysis of Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding thin film drugs market dynamics, structure by analysing the market segments, and project the global critical communication market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Thin Film Drugs Market make the report investor’s guide.
Thin Film Drugs Market Scope: Inquire before buying
| Global Thin Film Drugs Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | USD 9.60 Billion |
| Forecast Period 2024 to 2030 CAGR: | 11.10% | Market Size in 2030: | USD 20.07 Billion |
| Segments Covered: | by Product | Oral Thin Film Transdermal Thin Film Others |
|
| by Disease Indication | Schizophrenia Migraine Opioid Dependence Nausea & Vomiting Others |
||
Thin Film Drugs Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Thin Film Drugs Market Key Players are:
1.MonoSol Rx
2.Tesa Labtec GmbH
3.Pfizer, Inc.
4.Novartis AG
5.Wolters Kluwer
6.Solvay
7.Allergan plc.
8.Sumitomo Dainippon Pharma Co., Ltd.
9.IntelGenx Corp
10.Transition Therapeutics, Inc.
11.Allergan plc.
12.ZIM Laboratories Limited
13.Indivior plc
14.Sanofi
15.Church & Dwight
16.Tapemark
Frequently Asked Questions:
1. Which region has the largest share in Global Thin Film Drugs Market?
Ans: North America region held the highest share in 2023.
2. What is the growth rate of Global Thin Film Drugs Market?
Ans: The Global market is expected to growing at a CAGR of 11.10% during forecast period 2024-2030.
3. What is scope of the Global Thin Film Drugs market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Thin Film Drugs market?
Ans: The important key players in the Global market are , MonoSol Rx, Tesa Labtec GmbH, Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, Allergan plc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp, Transition Therapeutics, Inc., Allergan plc., ZIM Laboratories Limited, Indivior plc, Sanofi, Church & Dwight, and Tapemark.
5. What was the Global Thin Film Drugs Market size in 2023?
Ans: The Global Thin Film Drugs Market size was USD 9.60 Billion in 2023..